Please login to the form below
epilepsy
This page shows the latest epilepsy news and features for those working in and with pharma, biotech and healthcare.
10,000 autistic people to take part in the UK’s largest study of autism
Many autistic people have additional physical health conditions, such as epilepsy, or mental health conditions, such as anxiety or depression. ... Spectrum 10K hopes to answer questions such as why some autistic people have epilepsy or poor mental health
Latest news
-
Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
This was driven by competition for epilepsy drug Lyrica (pregabalin) in the US, as well as lower revenue for key drugs in China due to the impact from the country’s
-
Sanofi faces manslaughter allegations in France over Depakine deaths
Sanofi is being investigated for manslaughter charges in France relating to side-effects caused by the company’s anti-epilepsy drug Depakine (valproate). ... This means that women treated with Depakine for epilepsy were up to four times likelier to
-
US piles pressure on Mallinckrodt over alleged Acthar fraud
thanks to new indications, including a 2010 approval – under a New Drug Application – for the treatment of infantile spasms, an extremely rare, potentially fatal form of epilepsy.
-
Sanofi indicted in France over epilepsy drug birth defects
Sanofi has revealed that it has been indicted in France in connection with an investigation over birth defects linked to one of its epilepsy drugs. ... Despite its maturity, the drug has been one of Sanofi’s reliable mid-size products, bringing in
-
Congenica launches new application Congenica Neuro
Provides faster analysis of epilepsy and neurodevelopmental disorders. Digital health company Congenica has launched a new application on its clinical decision support programme named Congenica Neuro. . ... Around 300 million people around the world
More from news
Approximately 32 fully matching, plus 183 partially matching documents found.
Latest Intelligence
-
New thinking, bold action: building a better future for people living with severe diseases
For people living with severe neurological conditions like epilepsy, the struggles of the past year were multiplied. ... We recently announced our investment in the launch of Nile AI, a new independent company created to develop an epilepsy care
-
The changing nature of approvals – what does the future hold?
Therapeutics to focus on therapies for Parkinson’s, epilepsy and other central nervous system disorders.
-
Growing up as a patient is hard to manage
For example, studies show that approximately 38% of adolescents with epilepsy are non-adherent, whereby this increases to approximately 50% of adolescents with asthma reported as failing to take prescribed doses
-
Strengthening business competition and reducing anti-competitive practices
One of the largest was the £84.2m fine against Pfizer in 2016 for its 2, 600% price increase on an anti-epilepsy drug supplied to the NHS.
-
Drug launches to watch in 2019
The oral solution treats seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age or older, two of the most difficult-to-treat epilepsy-related ... a strong epilepsy or specialist disease experience.
More from intelligence
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest appointments
-
GW Pharmaceuticals strengthens research and development team
look forward to building on the progress of the Epidiolex programme in treatment resistant forms of epilepsy.”. ... science to provide breakthroughs not only in epilepsy but across a range of disease areas.
-
Turing names Eliseo Salinas as head of R&D
epilepsy, stroke, Parkinson's, attention deficit disorder and Alzheimer's disease.
-
GW hires Pfizer’s Kenneth Sommerville
in epilepsy, pain and other diseases.
-
Acorda appoints new CFO
This growth is led by six therapies in clinical studies that address a range of disorders including post-stroke deficits, epilepsy, cerebral palsy, stroke, peripheral nerve damage, spinal cord injury, neuropathic
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Lifesaving QR Code Wearable Launched to Help Emergency Services
We all know someone vulnerable, and people with conditions such as diabetes, epilepsy, and dementia could benefit from medical interventions during those critical moments.
-
OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
Addressing the inequality in access to Vagus Nerve Stimulation (VNS) Therapy to treat patients with Epilepsy entailed identifying delays in referrals and treatment, showing improvements in outcomes and stratifying patients suited
-
War on drugs: the use of controlled substances in medicine
It has shown promise in mental health conditions, skin conditions and a cannabis-based medicine is now available on the NHS for the treatment of epilepsy.
-
Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK
With three years’ healthcare communications experience, and a wealth of knowledge in epilepsy, immunotherapy and oncology Andrew comments, “I have had a very fulfilling first two months at Lucid; the team
-
Rare Disease Day 2018: Five things you should know about rare diseases.
some types of epilepsy are reported to affect about 100 families [9]).
War on drugs: the use of controlled substances in medicine
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
-
B2B media account director
-
Competitive salary
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- First trial of a vaccine against Alzheimer’s launches
- Merck enters agreement with Hanmi for investigational NASH drug
- Novo Nordisk growth takes a hit with China deal
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- First trial of a vaccine against Alzheimer’s launches
- The gold standard of scientific evidence
- AbbVie creates new aesthetics division amid Allergan takeover
- EU approves bluebird bio’s CALD gene therapy Skysona
- Organon buys Forendo in $1bn deal
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
